These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6127559)

  • 1. Does bromocriptine jeopardise the response to later yttrium-90 irradiation for macroprolactinemias?
    Ch'ng JL; Jung RT; Mashiter K; Bowley NB; Joplin GF
    Lancet; 1982 Nov; 2(8307):1099. PubMed ID: 6127559
    [No Abstract]   [Full Text] [Related]  

  • 2. Recurrent prolactinoma and meningioma following irradiation and bromocriptine treatment.
    Kolodny J; Dluhy RG
    Am J Med; 1985 Jan; 78(1):153-5. PubMed ID: 3966480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Space occupying growth of a pituitary adenoma producing hGH and hPrl during bromocriptin therapy.
    Halves E
    Clin Neurol Neurosurg; 1977; 80(4):251-7. PubMed ID: 216515
    [No Abstract]   [Full Text] [Related]  

  • 4. Bromocriptine: Does it jeopardise the result of later surgery for prolactinomas?
    Landolt AM; Keller PJ; Froesch ER; Mueller J
    Lancet; 1982 Sep; 2(8299):657-8. PubMed ID: 6125789
    [No Abstract]   [Full Text] [Related]  

  • 5. Transient intrasellar collection of air during bromocriptine treatment of a prolactinoma.
    Fagel WJ; Hekster RE; Smith SJ; van der Vijver JC
    Neuroradiology; 1986; 28(4):364-6. PubMed ID: 3762918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bromocriptine-induced cerebrospinal fluid rhinorrhea.
    Afshar F; Thomas A
    Surg Neurol; 1982 Jul; 18(1):61-3. PubMed ID: 7112390
    [No Abstract]   [Full Text] [Related]  

  • 7. Pregnancies in women with hyperprolactinaemia: clinical course and obstetric complications of 41 pregnancies in 27 women.
    Kelly WF; Doyle FH; Mashiter K; Banks LM; Gordon H; Joplin GF
    Br J Obstet Gynaecol; 1979 Sep; 86(9):698-705. PubMed ID: 497142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid enlargement of non-functioning pituitary tumour following withdrawal of bromocriptine.
    Clark JD; Wheatley T; Edwards OM
    J Neurol Neurosurg Psychiatry; 1985 Mar; 48(3):287. PubMed ID: 3981206
    [No Abstract]   [Full Text] [Related]  

  • 9. Cerebrospinal fluid rhinorrhea caused by bromocriptine therapy of prolactinoma.
    Holness RO; Shlossberg AH; Heffernan LP
    Neurology; 1984 Jan; 34(1):111-3. PubMed ID: 6537833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of bromocriptine and radiation on the size and activity of estrogen-induced rat prolactinomas.
    Hori T; Numata H; Hokama Y; Muraoka K; Saito Y; Kawamoto K
    Neurol Med Chir (Tokyo); 1985 Jan; 25(1):9-14. PubMed ID: 2581164
    [No Abstract]   [Full Text] [Related]  

  • 11. Long term suppression of prolactin concentrations after bromocriptine induced regression of pituitary prolactinomas.
    Hancock KW; Scott JS; Lamb JT; Gibson RM; Chapman C
    Br Med J (Clin Res Ed); 1985 Jan; 290(6462):117-8. PubMed ID: 3917709
    [No Abstract]   [Full Text] [Related]  

  • 12. Cerebrospinal fluid rhinorrhea: a complication of therapy for invasive prolactinomas.
    Landolt AM
    Neurosurgery; 1982 Sep; 11(3):395-401. PubMed ID: 7133356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of previous bromocriptine therapy on surgery for microprolactinoma.
    Faglia G; Moriondo P; Travaglini P; Giovanelli MA
    Lancet; 1983 Jan; 1(8316):133-4. PubMed ID: 6129452
    [No Abstract]   [Full Text] [Related]  

  • 14. Bromocriptine and pituitary tumours.
    Verde G; Chiodini PG; Liuzzi A; Favales F; Cozzi R
    Lancet; 1979 Sep; 2(8142):582. PubMed ID: 89580
    [No Abstract]   [Full Text] [Related]  

  • 15. Prolactin-producing pituitary tumors: medical therapy.
    Vaughn TC; Hammond CB
    Clin Obstet Gynecol; 1980 Jun; 23(2):403-11. PubMed ID: 6994967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the elution pattern of the serum and CSF prolactin fractionated by gel filtration chromatography in cases of bromocriptine-resistant prolactinoma].
    Sakamoto T; Kowada M; Hasegawa H; Ishino Y; Mineura K; Wakisaka A; Fukushima M
    Neurol Med Chir (Tokyo); 1987 Mar; 27(3):195-201. PubMed ID: 2442642
    [No Abstract]   [Full Text] [Related]  

  • 17. Reduction of pituitary-tumour size in patients with prolactinomas and acromegaly treated with bromocriptine with or without radiotherapy.
    Wass JA; Moult PJ; Thorner MO; Dacie JE; Charlesworth M; Jones AE; Besser GM
    Lancet; 1979 Jul; 2(8133):66-9. PubMed ID: 87966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of bromocriptine to maintain reduction in size of a macroprolactinoma.
    Breidahl HD; Topliss DJ; Pike JW
    Br Med J (Clin Res Ed); 1983 Aug; 287(6390):451-2. PubMed ID: 6411170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does bromocriptine have a cytocidal effect on prolactinoma cells? Report of a case.
    Gen M; Uozumi T; Shinohara S; Naito M; Ito A; Mori S; Kajiwara H
    Neurol Med Chir (Tokyo); 1983 Jan; 23(1):61-5. PubMed ID: 6188984
    [No Abstract]   [Full Text] [Related]  

  • 20. Bromocriptine treatment of prolactin-secreting tumors: surgical implications.
    Weiss MH; Wycoff RR; Yadley R; Gott P; Feldon S
    Neurosurgery; 1983 Jun; 12(6):640-2. PubMed ID: 6877546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.